BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8313228)

  • 21. The effect of fasting on the utilization of chylomicron triglyceride fatty acids in relation to clearing factor lipase (lipoprotein lipase) releasable by heparin in the perfused rat heart.
    Borensztajn J; Robinson DS
    J Lipid Res; 1970 Mar; 11(2):111-7. PubMed ID: 5418473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts.
    Rodrigues B; Spooner M; Severson DL
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E216-23. PubMed ID: 1539648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes.
    Qi D; Kuo KH; Abrahani A; An D; Qi Y; Heung J; Kewalramani G; Pulinilkunnil T; Ghosh S; Innis SM; Rodrigues B
    Cardiovasc Res; 2006 Oct; 72(1):124-33. PubMed ID: 16934788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats.
    Anandh Babu PV; Sabitha KE; Shyamaladevi CS
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1184-9. PubMed ID: 17184499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac lipoprotein lipase in the spontaneously hypertensive rat.
    Sambandam N; Chen X; Cam MC; Rodrigues B
    Cardiovasc Res; 1997 Feb; 33(2):460-8. PubMed ID: 9074711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-mediated modifications of myocardial lipoprotein lipase and lipoprotein metabolism.
    O'Looney P; Vander Maten M; Vahouny GV
    J Biol Chem; 1983 Nov; 258(21):12994-3001. PubMed ID: 6355100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible role of lipoprotein lipase in the regulation of endogenous triacylglycerols in the rat heart.
    Palmer WK; Caruso RA; Oscai LB
    Biochem J; 1981 Jul; 198(1):159-66. PubMed ID: 6173039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triacylglycerol lipase activities in isolated myocardial cells from chronically diabetic rat hearts.
    Severson DL; Larsen TS; Ramírez I
    Basic Res Cardiol; 1987; 82 Suppl 1():37-43. PubMed ID: 3663009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibition in vivo of lipoprotein lipase (clearing-factor lipase) activity by triton WR-1339.
    Borensztajn J; Rone MS; Kotlar TJ
    Biochem J; 1976 Jun; 156(3):539-43. PubMed ID: 949335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-transcriptional mechanisms are responsible for the reduction in lipoprotein lipase activity in cardiomyocytes from diabetic rat hearts.
    Carroll R; Liu L; Severson DL
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):67-72. PubMed ID: 7646474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion.
    Shearer GC; Kaysen GA
    Kidney Int; 2006 Aug; 70(4):647-53. PubMed ID: 16807550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-releasable and nonreleasable lipoprotein lipase in the perfused rat heart.
    Ben-Zeev O; Schwalb H; Schotz MC
    J Biol Chem; 1981 Oct; 256(20):10550-4. PubMed ID: 7287722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interference with the transport of heparin-releasable lipoprotein lipase in the perfused rat heart by colchicine and vinblastine.
    Chajek T; Stein O; Stein Y
    Biochim Biophys Acta; 1975 May; 388(2):260-8. PubMed ID: 1138898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased cardiac lipoprotein lipase activity in rats treated chronically with adriamycin.
    Thayer WS
    Life Sci; 1985 Feb; 36(7):635-41. PubMed ID: 3968980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal mediation of rat heart lipoprotein lipase activity after fat feeding.
    Pedersen ME; Wolf LE; Schotz MC
    Biochim Biophys Acta; 1981 Oct; 666(1):191-7. PubMed ID: 6271234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.
    Carroll R; Juhasz A; Severson DL
    Biochem J; 1990 Sep; 270(2):391-5. PubMed ID: 2169239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of lipoprotein lipase from cardiac myocytes by low-molecular weight heparin.
    Braun JE; Severson DL
    Lipids; 1993 Jan; 28(1):59-61. PubMed ID: 8383273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long term incubation of cardiac myocytes with oleic acid and very-low density lipoprotein reduces heparin-releasable lipoprotein lipase activity.
    Rodrigues B; Spooner MR; Severson DL
    Mol Cell Biochem; 1992 Oct; 116(1-2):33-7. PubMed ID: 1480152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein lipase in heart and myocytes: characteristics with intralipid as substrate.
    Perenna Rogers M; Dale A; Etienne J; Younan S
    Comp Biochem Physiol B; 1992 Mar; 101(3):327-31. PubMed ID: 1582175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cold exposure on heart clearing factor lipase and triglyceride utilization in the rat.
    Rogers MP; Robinson DS
    J Lipid Res; 1974 May; 15(3):263-72. PubMed ID: 4827916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.